Skip to main content

Recent Post (Use Desktop Site In mobile)

What are the points of the topic illiteracy leading to poverty in India?

There is a direct relationship between education and birth control. The higher the literacy rate, the lower the number of children per woman. If the balance between the resources and the population of the country is maintained, every person will get adequate food and financial assistance. Unemployment rate will be reduced and people will be able to live a prosperous life. Illiteracy can be considered one of the many reasons for poverty. Or one can say that illiteracy pushes up poverty and vice versa. Let's see how illiteracy causes poverty. Consider a poor illiterate person say, X . As he is illiterate ,chances of him getting employment in formal sectors is slim. Consequently he'll be forced to work in the informal sector. As you might know in informal sectors there is no job security and the income is also merge  . Assume that he lives in a family of 5, thus his merge income will not be sufficient to fend for 5. This makes him poor. Now assume that one of hi...

India’s 1st vaccine candidate COVAXIN

In India, there are more than 500,000 cases of corona, a vaccine called Covacin making hope to India.


Pharma major Bharat Biotech has announced the development of India’s 1st vaccine candidate for COVID-19, named COVAXIN, in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said, “We are proud to announce COVAXIN, India’s first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine. The proactive support and guidance from CDSCO have enabled approvals to this project. Our R&D and manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform.”

CDSCO and Ministry of Health and Family Welfare have granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

Source : DNA

Comments